01.12.2014 | Editorial Commentary
Are SPECT measurements of myocardial blood flow and flow reserve ready for clinical use?
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 12/2014
Einloggen, um Zugang zu erhaltenExcerpt
The well-documented diagnostic accuracy of SPECT myocardial perfusion imaging (MPI) for detecting coronary artery disease (CAD) has promoted its widespread clinical use. Nevertheless, the success of SPECT MPI has been attained using the basic SPECT camera design which is over 50 years old [1], using the basic filtered backprojection reconstruction algorithm which is even older, dating to over 90 years ago [2], and using 99mTc-based perfusion agents with limited extraction fractions [3]. Moreover, although SPECT MPI is inherently a digital quantitative technique, our clinical approach to quantifying hypoperfusion has depended on a database approach where a patient’s left ventricular perfusion pattern is statistically compared to an expected normal perfusion pattern generated from patients with a low likelihood of CAD [4‐6]. In spite of the success of SPECT MPI using these established conventional approaches, recent innovations are poised to bring SPECT MPI to the next level. In a recent article in EJNMMI, Hsu et al. [7] report on the use of dynamic SPECT with a SPECT/CT camera to measure absolute myocardial blood flow (MBF) and MBF reserve (MBFR) in patients. The authors conclude that their flow quantitation method is a clinically effective approach to enhancing CAD detection. Thus it is pertinent to ask: are SPECT measurements of MBF and MBFR ready for clinical use? …Anzeige